Cameco Corp (CCJ) concluded trading on Wednesday at a closing price of $51.38, with 5.2 million shares of worth about $267.13 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -4.36% during that period and on January 08, 2025 the price saw a loss of about -0.39%. Currently the company’s common shares owned by public are about 435.18M shares, out of which, 433.32M shares are available for trading.
Stock saw a price change of -0.02% in past 5 days and over the past one month there was a price change of -15.85%. Year-to-date (YTD), CCJ shares are showing a performance of -0.02% which increased to 20.30% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $35.43 but also hit the highest price of $62.55 during that period. The average intraday trading volume for Cameco Corp shares is 4.17 million. The stock is currently trading -3.60% below its 20-day simple moving average (SMA20), while that difference is down -6.38% for SMA50 and it goes to 3.76% higher than SMA200.
Cameco Corp (NYSE: CCJ) currently have 435.18M outstanding shares and institutions hold larger chunk of about 76.51% of that.
The stock has a current market capitalization of $22.36B and its 3Y-monthly beta is at 0.94. PE ratio of stock for trailing 12 months is 261.74, while it has posted earnings per share of $0.20 in the same period. Its PEG reads 4.03 and has Quick Ratio of 1.26 while making debt-to-equity ratio of 0.21. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CCJ, volatility over the week remained 4.55% while standing at 3.67% over the month.
Stock’s fiscal year EPS is expected to drop by -25.54% while it is estimated to increase by 170.97% in next year. EPS is likely to grow at an annualized rate of 65.00% for next 5-years, compared to annual growth of 13.73% made by the stock over the past 5-years.
Coverage by Goldman stated Cameco Corp (CCJ) stock as a Buy in their note to investors on April 01, 2024, suggesting a price target of $55 for the stock. Stock get an Outperform rating from BMO Capital Markets on November 08, 2023.
